Literature DB >> 21553668

Policy implications of first-dollar coverage: a qualitative examination from the payer perspective.

Emily F Shortridge1, Jonathan R Moore, Heidi Whitmore, Michael J O'Grady, Angela K Shen.   

Abstract

OBJECTIVES: Immunization against potentially life-threatening illnesses for children and adults has proved to be one of the great public health successes of the 20th century and is extremely cost-effective. The Patient Protection and Affordable Care Act includes a number of provisions to increase coverage and access to immunizations for the consumer, including a provision for health plans to cover all Advisory Committee on Immunization Practices-recommended vaccines at first dollar, or without cost sharing. In this study, we examined payers' perspectives on first-dollar coverage of vaccines and strategies to improve vaccination rates.
METHODS: This was a qualitative study, using a literature review and semistructured expert interviews with payers.
RESULTS: Four key themes emerged, including (1) the cost implications of the first-dollar change; (2) the importance of examining barriers to children, adolescents, and adults separately to focus interventions more strategically; (3) the importance of provider knowledge and education in increasing immunization; and (4) the effect of first-dollar coverage on those who decline vaccination for personal reasons.
CONCLUSIONS: We determined that, while reducing financial barriers through first-dollar coverage is an important first step to increasing immunization rates, there are structural and cultural barriers that also will require collaborative, strategic work among all vaccine stakeholders.

Entities:  

Mesh:

Year:  2011        PMID: 21553668      PMCID: PMC3072861          DOI: 10.1177/003335491112600313

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  14 in total

1.  Cost-sharing and the utilization of clinical preventive services.

Authors:  G Solanki; H H Schauffler
Journal:  Am J Prev Med       Date:  1999-08       Impact factor: 5.043

2.  Employer coverage of clinical preventive services in the United States.

Authors:  Maris Ann Bondi; Jeffrey R Harris; David Atkins; Molly E French; Beth Umland
Journal:  Am J Health Promot       Date:  2006 Jan-Feb

3.  Introduction: strengthening the delivery of new vaccines for adolescents.

Authors:  Mary M McCauley; Daniel B Fishbein; Jeanne M Santoli
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

4.  When and why children fall behind with vaccinations: missed visits and missed opportunities at milestone ages.

Authors:  Elizabeth T Luman; Susan Y Chu
Journal:  Am J Prev Med       Date:  2008-12-05       Impact factor: 5.043

5.  Vaccine financing in the United States: an emerging crisis.

Authors:  Grace M Lee; Tracy A Lieu
Journal:  Arch Pediatr Adolesc Med       Date:  2009-05

6.  Vaccination in the United States: payer perspective on the working group and its recommendations.

Authors:  Alan B Rosenberg
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

7.  Childhood immunization programs: an analysis of policy issues.

Authors:  G L Freed; W C Bordley; G H DeFriese
Journal:  Milbank Q       Date:  1993       Impact factor: 4.911

8.  National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines.

Authors:  Cynthia M Rand; Laura P Shone; Christina Albertin; Peggy Auinger; Jonathan D Klein; Peter G Szilagyi
Journal:  Arch Pediatr Adolesc Med       Date:  2007-03

9.  How can immunization coverage in urban counties be improved? A pilot study of a Kansas county.

Authors:  Angelia M Paschal; J'Vonnah Maryman; Julie Oler-Manske
Journal:  Am J Infect Control       Date:  2009-06       Impact factor: 2.918

10.  Gaps in vaccine financing for underinsured children in the United States.

Authors:  Grace M Lee; Jeanne M Santoli; Claire Hannan; Mark L Messonnier; James E Sabin; Donna Rusinak; Charlene Gay; Susan M Lett; Tracy A Lieu
Journal:  JAMA       Date:  2007-08-08       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.